A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.
Identifieur interne : 000140 ( Main/Corpus ); précédent : 000139; suivant : 000141A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.
Auteurs : S Udhaya Kumar ; N Madhana Priya ; S R Nithya ; Priyanka Kannan ; Nikita Jain ; D Thirumal Kumar ; R. Magesh ; Salma Younes ; Hatem Zayed ; C George Priya DossSource :
- 3 Biotech [ 2190-572X ] ; 2021.
Abstract
Coronavirus disease (COVID-19) pandemic is instigated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of March 13, 2021, more than 118.9 million cases were infected with COVID-19 worldwide. SARS-CoV-2 is a positive-sense single-stranded RNA beta-CoV. Most COVID-19 infected individuals recover within 1-3 weeks. Nevertheless, approximately 5% of patients develop acute respiratory distress syndrome and other systemic complications, leading to death. Structural genetic analyses of SARS-CoV-2 have shown genomic resemblances but a low evolutionary correlation to SARS-CoV-1 responsible for the 2002-2004 outbreak. The S glycoprotein is critical for cell adhesion and the entrance of the virus into the host. The process of cell entry uses the cellular receptor named angiotensin-converting enzyme 2. Recent evidence proposed that the CD147 as a SARS-CoV-2's potential receptor. The viral genome is mainly held by two non-structural proteins (NSPs), ORF1a and ORF1ab, along with structural proteins. Although NSPs are conserved among the βCoVs, mutations in NSP2 and NSP3 may play critical roles in transmitting the virus and cell tropism. To date, no specific/targeted anti-viral treatments exist. Notably, more than 50 COVID-19 candidate vaccines in clinical trials, and a few being administered. Preventive precautions are the primary strategy to limit the viral load transmission and spread, emphasizing the urgent need for developing significant drug targets and vaccines against COVID-19. This review provides a cumulative overview of the genomic structure, transmission, phylogeny of SARS-CoV-2 from Indian clusters, treatment options, updated discoveries, and future standpoints for COVID-19.
Supplementary Information
The online version contains supplementary material available at 10.1007/s13205-021-02749-0.
DOI: 10.1007/s13205-021-02749-0
PubMed: 33816047
PubMed Central: PMC8003899
Links to Exploration step
pubmed:33816047Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.</title>
<author><name sortKey="Kumar, S Udhaya" sort="Kumar, S Udhaya" uniqKey="Kumar S" first="S Udhaya" last="Kumar">S Udhaya Kumar</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Priya, N Madhana" sort="Priya, N Madhana" uniqKey="Priya N" first="N Madhana" last="Priya">N Madhana Priya</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nithya, S R" sort="Nithya, S R" uniqKey="Nithya S" first="S R" last="Nithya">S R Nithya</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kannan, Priyanka" sort="Kannan, Priyanka" uniqKey="Kannan P" first="Priyanka" last="Kannan">Priyanka Kannan</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jain, Nikita" sort="Jain, Nikita" uniqKey="Jain N" first="Nikita" last="Jain">Nikita Jain</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kumar, D Thirumal" sort="Kumar, D Thirumal" uniqKey="Kumar D" first="D Thirumal" last="Kumar">D Thirumal Kumar</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Magesh, R" sort="Magesh, R" uniqKey="Magesh R" first="R" last="Magesh">R. Magesh</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Younes, Salma" sort="Younes, Salma" uniqKey="Younes S" first="Salma" last="Younes">Salma Younes</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zayed, Hatem" sort="Zayed, Hatem" uniqKey="Zayed H" first="Hatem" last="Zayed">Hatem Zayed</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Doss, C George Priya" sort="Doss, C George Priya" uniqKey="Doss C" first="C George Priya" last="Doss">C George Priya Doss</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33816047</idno>
<idno type="pmid">33816047</idno>
<idno type="doi">10.1007/s13205-021-02749-0</idno>
<idno type="pmc">PMC8003899</idno>
<idno type="wicri:Area/Main/Corpus">000140</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000140</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.</title>
<author><name sortKey="Kumar, S Udhaya" sort="Kumar, S Udhaya" uniqKey="Kumar S" first="S Udhaya" last="Kumar">S Udhaya Kumar</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Priya, N Madhana" sort="Priya, N Madhana" uniqKey="Priya N" first="N Madhana" last="Priya">N Madhana Priya</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nithya, S R" sort="Nithya, S R" uniqKey="Nithya S" first="S R" last="Nithya">S R Nithya</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kannan, Priyanka" sort="Kannan, Priyanka" uniqKey="Kannan P" first="Priyanka" last="Kannan">Priyanka Kannan</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jain, Nikita" sort="Jain, Nikita" uniqKey="Jain N" first="Nikita" last="Jain">Nikita Jain</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kumar, D Thirumal" sort="Kumar, D Thirumal" uniqKey="Kumar D" first="D Thirumal" last="Kumar">D Thirumal Kumar</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Magesh, R" sort="Magesh, R" uniqKey="Magesh R" first="R" last="Magesh">R. Magesh</name>
<affiliation><nlm:affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Younes, Salma" sort="Younes, Salma" uniqKey="Younes S" first="Salma" last="Younes">Salma Younes</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zayed, Hatem" sort="Zayed, Hatem" uniqKey="Zayed H" first="Hatem" last="Zayed">Hatem Zayed</name>
<affiliation><nlm:affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Doss, C George Priya" sort="Doss, C George Priya" uniqKey="Doss C" first="C George Priya" last="Doss">C George Priya Doss</name>
<affiliation><nlm:affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">3 Biotech</title>
<idno type="ISSN">2190-572X</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Coronavirus disease (COVID-19) pandemic is instigated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of March 13, 2021, more than 118.9 million cases were infected with COVID-19 worldwide. SARS-CoV-2 is a positive-sense single-stranded RNA beta-CoV. Most COVID-19 infected individuals recover within 1-3 weeks. Nevertheless, approximately 5% of patients develop acute respiratory distress syndrome and other systemic complications, leading to death. Structural genetic analyses of SARS-CoV-2 have shown genomic resemblances but a low evolutionary correlation to SARS-CoV-1 responsible for the 2002-2004 outbreak. The S glycoprotein is critical for cell adhesion and the entrance of the virus into the host. The process of cell entry uses the cellular receptor named angiotensin-converting enzyme 2. Recent evidence proposed that the CD147 as a SARS-CoV-2's potential receptor. The viral genome is mainly held by two non-structural proteins (NSPs), ORF1a and ORF1ab, along with structural proteins. Although NSPs are conserved among the βCoVs, mutations in NSP2 and NSP3 may play critical roles in transmitting the virus and cell tropism. To date, no specific/targeted anti-viral treatments exist. Notably, more than 50 COVID-19 candidate vaccines in clinical trials, and a few being administered. Preventive precautions are the primary strategy to limit the viral load transmission and spread, emphasizing the urgent need for developing significant drug targets and vaccines against COVID-19. This review provides a cumulative overview of the genomic structure, transmission, phylogeny of SARS-CoV-2 from Indian clusters, treatment options, updated discoveries, and future standpoints for COVID-19.</div>
<div type="abstract" xml:lang="en"><p><b>Supplementary Information</b>
</p>
<p>The online version contains supplementary material available at 10.1007/s13205-021-02749-0.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33816047</PMID>
<DateRevised><Year>2021</Year>
<Month>04</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2190-572X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>4</Issue>
<PubDate><Year>2021</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>3 Biotech</Title>
<ISOAbbreviation>3 Biotech</ISOAbbreviation>
</Journal>
<ArticleTitle>A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.</ArticleTitle>
<Pagination><MedlinePgn>198</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s13205-021-02749-0</ELocationID>
<Abstract><AbstractText>Coronavirus disease (COVID-19) pandemic is instigated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of March 13, 2021, more than 118.9 million cases were infected with COVID-19 worldwide. SARS-CoV-2 is a positive-sense single-stranded RNA beta-CoV. Most COVID-19 infected individuals recover within 1-3 weeks. Nevertheless, approximately 5% of patients develop acute respiratory distress syndrome and other systemic complications, leading to death. Structural genetic analyses of SARS-CoV-2 have shown genomic resemblances but a low evolutionary correlation to SARS-CoV-1 responsible for the 2002-2004 outbreak. The S glycoprotein is critical for cell adhesion and the entrance of the virus into the host. The process of cell entry uses the cellular receptor named angiotensin-converting enzyme 2. Recent evidence proposed that the CD147 as a SARS-CoV-2's potential receptor. The viral genome is mainly held by two non-structural proteins (NSPs), ORF1a and ORF1ab, along with structural proteins. Although NSPs are conserved among the βCoVs, mutations in NSP2 and NSP3 may play critical roles in transmitting the virus and cell tropism. To date, no specific/targeted anti-viral treatments exist. Notably, more than 50 COVID-19 candidate vaccines in clinical trials, and a few being administered. Preventive precautions are the primary strategy to limit the viral load transmission and spread, emphasizing the urgent need for developing significant drug targets and vaccines against COVID-19. This review provides a cumulative overview of the genomic structure, transmission, phylogeny of SARS-CoV-2 from Indian clusters, treatment options, updated discoveries, and future standpoints for COVID-19.</AbstractText>
<AbstractText Label="Supplementary Information" NlmCategory="UNASSIGNED">The online version contains supplementary material available at 10.1007/s13205-021-02749-0.</AbstractText>
<CopyrightInformation>© King Abdulaziz City for Science and Technology 2021.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kumar</LastName>
<ForeName>S Udhaya</ForeName>
<Initials>SU</Initials>
<Identifier Source="ORCID">0000-0002-6639-3746</Identifier>
<AffiliationInfo><Affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</Affiliation>
<Identifier Source="GRID">grid.412813.d</Identifier>
<Identifier Source="ISNI">0000 0001 0687 4946</Identifier>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Priya</LastName>
<ForeName>N Madhana</ForeName>
<Initials>NM</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nithya</LastName>
<ForeName>S R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kannan</LastName>
<ForeName>Priyanka</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jain</LastName>
<ForeName>Nikita</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</Affiliation>
<Identifier Source="GRID">grid.412813.d</Identifier>
<Identifier Source="ISNI">0000 0001 0687 4946</Identifier>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kumar</LastName>
<ForeName>D Thirumal</ForeName>
<Initials>DT</Initials>
<Identifier Source="ORCID">0000-0002-5545-606X</Identifier>
<AffiliationInfo><Affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</Affiliation>
<Identifier Source="GRID">grid.412813.d</Identifier>
<Identifier Source="ISNI">0000 0001 0687 4946</Identifier>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Magesh</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Tamil Nadu, Porur, Chennai, 600116 India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Younes</LastName>
<ForeName>Salma</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</Affiliation>
<Identifier Source="GRID">grid.412603.2</Identifier>
<Identifier Source="ISNI">0000 0004 0634 1084</Identifier>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zayed</LastName>
<ForeName>Hatem</ForeName>
<Initials>H</Initials>
<Identifier Source="ORCID">0000-0001-8838-6638</Identifier>
<AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Health and Sciences, QU Health, Qatar University, Doha, Qatar.</Affiliation>
<Identifier Source="GRID">grid.412603.2</Identifier>
<Identifier Source="ISNI">0000 0004 0634 1084</Identifier>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Doss</LastName>
<ForeName>C George Priya</ForeName>
<Initials>CGP</Initials>
<Identifier Source="ORCID">0000-0002-5971-8290</Identifier>
<AffiliationInfo><Affiliation>Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology, Tamil Nadu, Vellore, 632 014 India.</Affiliation>
<Identifier Source="GRID">grid.412813.d</Identifier>
<Identifier Source="ISNI">0000 0001 0687 4946</Identifier>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>03</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>3 Biotech</MedlineTA>
<NlmUniqueID>101565857</NlmUniqueID>
<ISSNLinking>2190-5738</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">COVID-19 molecular diagnosis</Keyword>
<Keyword MajorTopicYN="N">COVID-19 therapeutics</Keyword>
<Keyword MajorTopicYN="N">Drug repurposing</Keyword>
<Keyword MajorTopicYN="N">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">India</Keyword>
<Keyword MajorTopicYN="N">Protease</Keyword>
<Keyword MajorTopicYN="N">Remdesivir</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2 genome</Keyword>
<Keyword MajorTopicYN="N">Vaccines</Keyword>
</KeywordList>
<CoiStatement>Conflict of interestThe authors have declared that no conflicts of interest exist.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>08</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2021</Year>
<Month>03</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>4</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>5</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33816047</ArticleId>
<ArticleId IdType="doi">10.1007/s13205-021-02749-0</ArticleId>
<ArticleId IdType="pii">2749</ArticleId>
<ArticleId IdType="pmc">PMC8003899</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Nature. 2020 Mar;579(7800):482-483</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32203366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2020 Mar;22(2):80-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32087334</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32404480</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2004 Aug;3(8):673-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15286734</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Occup Environ Med. 2020 Feb 5;11(2):65-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020915</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1985 Mar;53(3):834-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2983094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cureus. 2020 Mar 21;12(3):e7355</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32328367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W260-W265</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31028399</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2010 May;1802(5):485-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20153823</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2007 Nov 2;282(44):32208-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17761676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1983;2(10):1839-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6196191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1985 Nov;56(2):449-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2997467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32201449</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31995857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bioimpacts. 2020;10(4):209-215</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32983936</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AJR Am J Roentgenol. 2020 May;214(5):1078-1082</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32108495</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):221-236</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31987001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Proteome Res. 2020 Apr 3;19(4):1351-1360</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32200634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2020 Oct 2;287:198098</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32687861</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Evol. 2013 Apr;30(4):772-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23329690</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chem Neuroanat. 2020 Dec;110:101874</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33091590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pan Afr Med J. 2020 Jun 09;36:80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32774639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Cent Sci. 2020 Mar 25;6(3):315-331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32226821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2020 Apr;8(4):e488-e496</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32119825</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Evol. 2015 Oct;32(10):2798-800</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26130081</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viruses. 2014 Aug 07;6(8):2991-3018</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25105276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32747721</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Evol Biol. 2010 Jul 13;10:210</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20626897</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2020 May 1;432(10):3309-3325</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320687</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Feb;79(4):2506-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15681451</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Pharmacol Rep. 2020 May 11;:1-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32395418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Virol. 2016 Sep 29;3(1):237-261</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27578435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Open Forum Infect Dis. 2020 Sep 18;7(11):ofaa434</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33200080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2021 Mar;93(3):1722-1731</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32966646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32155444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2019 May 27;16(1):69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31133031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):69-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31996494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 2020 Jul 1;98(7):495-504</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32742035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):778-785</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32198501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Oct 6;324(13):1307-1316</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32876695</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Cell Biol. 2021 Jan;99(1):21-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32864735</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19626045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>3 Biotech. 2020 Oct;10(10):435</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32959007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biomed Res Int. 2020 May 30;2020:4389089</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32596311</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2019 Jan;18(1):41-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30310233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Oct 6;324(13):1317-1329</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32876697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2011 Jun;10(6):428-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21629293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pathogens. 2020 Mar 04;9(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32143502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32269081</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 May 1;368(6490):489-493</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32179701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2019 Jan;18(1):1-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29880920</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Virus Res. 2006;66:193-292</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16877062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viruses. 2020 Feb 22;12(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32098422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 May;84(9):4619-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20181693</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Med (Lausanne). 2020 May 22;7:250</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32574338</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Med (Lausanne). 2020 Jul 02;7:355</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32714937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2019 Jul;167:45-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30974127</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30931475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2020 Mar;19(3):149-150</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32127666</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2005 May;86(Pt 5):1423-1434</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15831954</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosens Bioelectron. 2020 Oct 15;166:112455</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32739797</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Jul;75(7):1699-1709</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Microbiol. 2020 Apr;5(4):562-569</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32094589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Pharmacol. 2020 Mar-Apr;52(2):142-149</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32565603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1984 Jun;81(12):3626-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6328522</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Structure. 2005 Dec;13(12):1859-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16338414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Comput Biol Med. 2020 Jun;121:103749</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32568687</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Aug 12;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32785710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2020 Dec 10;15(12):e0243270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33301474</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2020 Jun;178:104787</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32251768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pathog Immun. 2020 Oct 19;5(1):342-363</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33154981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci China Life Sci. 2020 Mar;63(3):461-462</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32048160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>mBio. 2012 Nov 20;3(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chembiochem. 2020 Mar 2;21(5):730-738</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32022370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Apr;92(4):418-423</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31967327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Nov;74(22):10600-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11044104</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2020 Apr;176:104742</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32057769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol Sin. 2016 Feb;31(1):3-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26847650</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32350134</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1999 May;73(5):3737-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10196267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):597-600</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32174267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bioinformatics. 2010 Jul 1;26(13):1669-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20472542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Biotechnol. 2020 Jul;38(7):777</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32641848</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2009 Jul;83(13):6689-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19369340</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Nov;87(21):11955-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23986593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Comput Biol. 2002;9(5):687-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12487758</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2015 Jul;14(7):475-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26091267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biophys J. 2006 Jul 15;91(2):508-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16648166</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2020 Jun 30;527(3):618-623</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32416961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Rev. 1998 Oct;11(4):614-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9767059</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2015;1282:1-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25720466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Soc Trans. 2011 Oct;39(5):1371-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21936817</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105933</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32147516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Microbiol Immunol Infect. 2020 Mar 31;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32265180</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Jul;583(7816):459-468</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32353859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Apr 18;395(10232):1245-1246</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32305088</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2020 Apr 21;64(5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32152082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Med Microbiol. 2020 Apr-Jun;38(2):210-212</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32883935</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000140 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000140 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33816047 |texte= A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33816047" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |